{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T09:11:54Z","timestamp":1719911514769},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DZHK (Deutsches Zentrum f\u00fcr Herz-Kreislauf-Forschung)"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yjmcc.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T19:25:44Z","timestamp":1434223544000},"page":"226-228","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Firefighting in viral myocarditis \u2014 Extinguish galectin-3 to control the inflamed heart?"],"prefix":"10.1016","volume":"85","author":[{"given":"Diana","family":"Lindner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2015.06.004_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2015.05.010","article-title":"Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis","volume":"85","author":"De Giusti","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.pharmtox.010909.105812","article-title":"Macrophages and tissue injury: agents of defense or destruction?","volume":"51","author":"Laskin","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0015","doi-asserted-by":"crossref","first-page":"519528","DOI":"10.1155\/2014\/519528","article-title":"Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication","volume":"2014","author":"Lindner","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0020","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCRESAHA.108.192179","article-title":"CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis","volume":"104","author":"Yuan","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0025","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.4049\/jimmunol.176.6.3516","article-title":"Complement receptor 1 and 2 deficiency increases coxsackievirus B3-induced myocarditis, dilated cardiomyopathy, and heart failure by increasing macrophages, IL-1beta, and immune complex deposition in the heart","volume":"176","author":"Fairweather","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0030","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/eji.200939389","article-title":"Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control","volume":"39","author":"Fink","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1348-0421.1998.tb02331.x","article-title":"Role of macrophages in acute murine cytomegalovirus infection","volume":"42","author":"Hamano","year":"1998","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0040","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1124\/jpet.114.218370","article-title":"Functions of galectin-3 and its role in fibrotic diseases","volume":"351","author":"Li","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0045","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00747.2008","article-title":"N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion\/growth-regulatory lectin","volume":"296","author":"Liu","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodeling pathways in heart failure","volume":"443","author":"Passino","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0060","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/CIRCULATIONAHA.111.035964","article-title":"Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy","volume":"124","author":"Westermann","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-2567.1998.00517.x","article-title":"Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice","volume":"94","author":"Colnot","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0002-9440(10)64975-9","article-title":"Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses","volume":"156","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1023\/B:GLYC.0000014088.21242.e0","article-title":"Galectins as inflammatory mediators","volume":"19","author":"Almkvist","year":"2004","journal-title":"Glycoconj J"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0080","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.165.4.2156","article-title":"Human galectin-3 is a novel chemoattractant for monocytes and macrophages","volume":"165","author":"Sano","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.imbio.2011.07.031","article-title":"Galectin-3 inhibits the chemotaxis of human polymorphonuclear neutrophils in vitro","volume":"217","author":"Baseras","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0090","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000324864","article-title":"Human galectins induce conversion of dermal fibroblasts into myofibroblasts and production of extracellular matrix: potential application in tissue engineering and wound repair","volume":"194","author":"Dvorankova","year":"2011","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.273","article-title":"State of the art: newer biomarkers in heart failure","author":"de Boer","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2015.05.040","article-title":"Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort","volume":"192","author":"Jagodzinski","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.yjmcc.2015.06.004_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ejhf.246","article-title":"Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin","volume":"17","author":"Lopez","year":"2015","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281500190X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228281500190X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T16:57:22Z","timestamp":1537549042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228281500190X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":21,"alternative-id":["S002228281500190X"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.06.004","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Firefighting in viral myocarditis \u2014 Extinguish galectin-3 to control the inflamed heart?","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}